CorVista® Health

Heart disease isn’t just a personal health crisis — it’s a global one. Cardiovascular diseases (CVD) claim 17.9 million lives every year, making them the leading cause of death worldwide. Even more alarming, 1 in 3 of these deaths occurs in people under 70. Early detection may lower the chances of an acute event and reduce death rates in people with CVD. Our a non-invasive, point-of-care diagnostic system can detect and assess CVDs like pulmonary hypertension and coronary artery disease in one scan. Learn more about our diagnostic solution here: bit.ly/4cVYqcJ

The European Respiratory Journal has published compelling evidence that the CorVista System can accurately detect elevated mean pulmonary artery pressure (mPAP) – a hallmark of #PulmonaryHypertension. #PH remains vastly under diagnosed, with patients waiting an average of two and a half years from symptom onset to accurate diagnosis – often after disease progression has already compromised outcomes. The CorVista System offers a quick, non-invasive, stress-free test option conducted in under five minutes, enabling earlier and broader detection of PH. Learn more in our press release: bit.ly/4mn8kbJ

On #WorldPHDay we’re shining a light on #PulmonaryHypertension, a serious and often misdiagnosed disease that strains the lungs and heart, impacting lives across all ages. On average it takes 2.5 years from the first doctor's visit to receive an accurate PH diagnosis. We are committed to shortening then the diagnostic journey to minutes so patients can start treatment sooner. Learn more about PH through the @PHAssociation: bit.ly/439gv3A #WorldPHDay2025 #SometimesItsPH

Cardiovascular disease is the No. 1 killer of women, causing 1 in 3 deaths each year, yet only 44% of women recognize it as their greatest health threat. At CorVista, we believe most cardiovascular diseases can still be prevented with education and healthy lifestyle changes. ❤️ This #NationalWomensHealthMonth, we encourage women to prioritize their heart health. Learn what risk factors you can manage at @GoRedforWomen bit.ly/2sTrmNd

At #ACC25, we shared new data showing the potential of #ML algorithms to detect PCWP elevation, creating new opportunities for a possible non-invasive aid in HFpEF & #PH diagnosis. Read more: bit.ly/4cyZy5D

Our CEO, Adrian Lam, joined Tom Salemi on the #DeviceTalksWeekly Podcast to discuss CorVista’s approach to using #AI in #CardiacDiagnostics and life lessons from his career journey. 🎧 Listen here: devicetalks.com/corvista-using…

The CorVista System was featured in @PulmonaryNews, highlighting new data on its potential to support heart failure diagnosis by measuring elevated PCWP. Learn how this non-invasive, AI-powered technology could help deliver timely, accurate insights at the point of care. bit.ly/43HYeeu

The standard of care isn't accessible for many patients. This #NationalMinorityHealthMonth & beyond, we are dedicated to breaking down barriers in #CardiovascularCare and promoting healthcare access for all communities. Learn more here: bit.ly/43F1Kq0 #CloseTheCareGap

We recently shared new findings at #ACC25! Data show #MachineLearning algorithms may detect PCWP elevation, potentially aiding in HFpEF and #PH assessment. Discover how we are using the CorVista System to advance AI-driven solutions in heart disease diagnosis, here: bit.ly/4iSgXc3

We look forward to presenting new data at #ACC25 from our non-invasive point-of-care test for pulmonary capillary wedge pressure elevation using machine learning to assess for heart failure and #PulmonaryHypertension subtypes. Presentation Number: 1166-41 Date and Time: Sunday, March 30, 2025, at 12:00 p.m. ET – 1:00 p.m. ET Find more info here: bit.ly/4iJBRJZ

Our CEO, Adrian Lam, will join an expert panel discussion at @lsintelligence USA '25!​ Details:​ 🎤 How AI Will (and Already is) Revolutionizing Cardiovascular Care​ 📅 March 20, 11:20 a.m. PT​ Learn more here: bit.ly/4iqRkyD #LSIAlumni #LSIUSA25

Our CEO, Adrian Lam will take the stage at @lsintelligence, Medtech's premier partnering event, to present an overview of how CorVista is closing the #CardiovascularCare gap with our #MachineLearning based technology. Register here: bit.ly/4iqRkyD #LSIAlumni #LSIUSA25

At CorVista, we honor trailblazers in #CardiovascularCare. This #InternationalWomensDay, we celebrate Dr. Nanette Wenger, a heart health pioneer whose research transformed care for women. Her legacy inspires us to keep innovating to close the care gap: bit.ly/4cbZHvs

#AI & machine learning are revolutionizing healthcare—enhancing diagnostics & expanding access to underserved communities. CorVista shares insights on these non-invasive, data-driven solutions in this installation of @PharmaScrip Scrip Asks 2025: bit.ly/3PWQjBR

⏱️ Delays in cardiovascular care could impact outcomes as patients drop off in follow up & the disease progresses, increasing the risk of potential acute events. The CorVista® System has been shown to dramatically shorten the time to diagnosis. Learn more: bit.ly/3NmLkcl

Our CMO, Dr. Charles Bridges, joined the Empowered Patient Podcast to discuss challenges diagnosing #PulmonaryHypertension and how our non-invasive technology is enabling rapid, early detection of heart conditions. Listen here: bit.ly/3XjH3Mb

Cardiac care disparities often lead to delayed diagnoses, inadequate treatment, and higher mortality—especially in vulnerable communities. Our CSO, Charles Bridges shares how advances like the CorVistaSystem can help close the gap. ⬇️ Read more in @Biorasi below.

#DYK that while factors like age and family history are beyond your control, you can lower your risk of #HeartDisease by managing what’s within your reach? Understand the risk factors and protect your heart from cardiovascular disease. Learn more here: bit.ly/3E3j64V

Don Crawford is retiring as CEO after advancing CorVista's concept to a point-of-care diagnostic accessible to patients We thank him for his leadership & welcome Adrian Lam as our new CEO & Tim Attebery as BOD chairman. More here: bit.ly/42MuIUq

February is #AmericanHeartMonth. Did you know 22M Americans lack access to a cardiologist in their county? CorVista is bridging the gap with innovative point-of-care diagnostics-bringing heart health to rural and remote communities. Learn more: bit.ly/3PWTEB3